|4Mar 5, 6:34 PM ET

Carulli Michael 4

4 · PMV Pharmaceuticals, Inc. · Filed Mar 5, 2025

Insider Transaction Report

Form 4
Period: 2025-03-03
Carulli Michael
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-03-03+265,000265,000 total
    Exercise: $1.32Exp: 2035-03-03Common Stock (265,000 underlying)
Footnotes (1)
  • [F1]Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025.

Documents

1 file
  • 4
    form4-03052025_110309.xmlPrimary